Fierce Biotech2h
European VC shop Sofinnova closes €165M biotech acceleration fund with support from Amgen, BMS and Pfizer Ventures
After raising an impressive 1.2 billion euros in 2024, European venture capital firm Sofinnova Partners is topping up its ...
Amgen Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...